Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Sunil, Ives, Natalie, Brettell, Elizabeth A., Valente, Marie, Cockwell, Paul, Topham, Peter S., Cleland, John G., Khwaja, Arif, El Nahas, Meguid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
CLINICAL SCIENCE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://www.ncbi.nlm.nih.gov/pubmed/26429974
http://dx.doi.org/10.1093/ndt/gfv346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://www.ncbi.nlm.nih.gov/pubmed/26429974
http://dx.doi.org/10.1093/ndt/gfv346

Ejemplares similares